glp 1 weight loss supplement Swissmedic issues warning against falsified and misleading “GLP-1” products Daily GLP-1 Support – Midi

Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases

Currently, there is no definitive consensus that GLP-1 receptor agonists directly cause clinically significant bone density loss independent of their weight-reducing effects

Protein intake in adults should not fall below 0.40.5 g/kg/day, as this can lead to muscle atrophy and functional impairments, while prolonged intake above 2 g/kg/day should be avoided due to potential adverse health effects [157]

During rapid weight loss, the body may undergo metabolic adaptationsometimes called "adaptive thermogenesis"where energy expenditure decreases beyond what would be expected from reduced body mass alone